95 related articles for article (PubMed ID: 16029117)
1. Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1.
Chen H; Kunnimalaiyaan M; Van Gompel JJ
Thyroid; 2005 Jun; 15(6):511-21. PubMed ID: 16029117
[TBL] [Abstract][Full Text] [Related]
2. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
Sippel RS; Carpenter JE; Kunnimalaiyaan M; Chen H
Surgery; 2003 Dec; 134(6):866-71; discussion 871-3. PubMed ID: 14668716
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1.
Chen H; Carson-Walter EB; Baylin SB; Nelkin BD; Ball DW
Surgery; 1996 Aug; 120(2):168-72; discussion 173. PubMed ID: 8751579
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions.
Chen H; Biel MA; Borges MW; Thiagalingam A; Nelkin BD; Baylin SB; Ball DW
Cell Growth Differ; 1997 Jun; 8(6):677-86. PubMed ID: 9186001
[TBL] [Abstract][Full Text] [Related]
6. Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer.
Cook MR; Luo J; Ndiaye M; Chen H; Kunnimalaiyaan M
Am J Surg; 2010 Mar; 199(3):315-8; discussion 318. PubMed ID: 20226902
[TBL] [Abstract][Full Text] [Related]
7. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer.
Vaccaro A; Chen H; Kunnimalaiyaan M
Anticancer Drugs; 2006 Aug; 17(7):849-53. PubMed ID: 16926634
[TBL] [Abstract][Full Text] [Related]
8. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.
Truong M; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2011 May; 18(5):1506-11. PubMed ID: 21184191
[TBL] [Abstract][Full Text] [Related]
11. Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.
Adler JT; Cook M; Luo Y; Pitt SC; Ju J; Li W; Shen B; Kunnimalaiyaan M; Chen H
Mol Cancer Ther; 2009 Apr; 8(4):914-20. PubMed ID: 19372564
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor mediates atorvastatin-induced mammalian achaete-scute homologue-1 gene expression and neuronal differentiation after stroke in retired breeder rats.
Chen J; Zacharek A; Li A; Zhang C; Ding J; Roberts C; Lu M; Kapke A; Chopp M
Neuroscience; 2006 Aug; 141(2):737-744. PubMed ID: 16730914
[TBL] [Abstract][Full Text] [Related]
13. The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer.
Kebebew E; Treseler PA; Duh QY; Clark OH
Surgery; 2000 Dec; 128(6):952-7. PubMed ID: 11114629
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species are critical for the growth and differentiation of medullary thyroid carcinoma cells.
Ha HC; Thiagalingam A; Nelkin BD; Casero RA
Clin Cancer Res; 2000 Sep; 6(9):3783-7. PubMed ID: 10999773
[TBL] [Abstract][Full Text] [Related]
15. CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.
Strock CJ; Park JI; Rosen M; Dionne C; Ruggeri B; Jones-Bolin S; Denmeade SR; Ball DW; Nelkin BD
Cancer Res; 2003 Sep; 63(17):5559-63. PubMed ID: 14500395
[TBL] [Abstract][Full Text] [Related]
16. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation.
Carson EB; McMahon M; Baylin SB; Nelkin BD
Cancer Res; 1995 May; 55(10):2048-52. PubMed ID: 7743500
[TBL] [Abstract][Full Text] [Related]
17. Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases.
La Rosa S; Marando A; Gatti G; Rapa I; Volante M; Papotti M; Sessa F; Capella C
Hum Pathol; 2013 Jul; 44(7):1391-9. PubMed ID: 23375646
[TBL] [Abstract][Full Text] [Related]
18. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
[TBL] [Abstract][Full Text] [Related]
19. Expression of the active Notch1 decreases MTC tumor growth in vivo.
Jaskula-Sztul R; Pisarnturakit P; Landowski M; Chen H; Kunnimalaiyaan M
J Surg Res; 2011 Nov; 171(1):23-7. PubMed ID: 21571316
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis reveals novel sequence variants in NTRK1 in sporadic human medullary thyroid carcinoma.
Gimm O; Greco A; Hoang-Vu C; Dralle H; Pierotti MA; Eng C
J Clin Endocrinol Metab; 1999 Aug; 84(8):2784-7. PubMed ID: 10443680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]